Arianna Gentilini

124 posts

Arianna Gentilini banner
Arianna Gentilini

Arianna Gentilini

@agentilini_

Postdoctoral Researcher @ImperialBiz | PhD @LSEHealthPolicy

London Bergabung Haziran 2022
408 Mengikuti149 Pengikut
Arianna Gentilini me-retweet
LSE Health Policy
LSE Health Policy@LSEHealthPolicy·
𝐖𝐡𝐲 𝐂𝐨𝐫𝐫𝐮𝐩𝐭𝐢𝐨𝐧 𝐏𝐞𝐫𝐬𝐢𝐬𝐭𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐒𝐞𝐜𝐭𝐨𝐫 💰 Corruption drains budgets, erodes trust & fuels inequality in Europe’s health systems. Why does it persist? 👉 Read Iva Parvanova’s blog here: bit.ly/43YOScF
English
0
4
9
537
Dr. Mylene Lagarde
Dr. Mylene Lagarde@mylene_lagarde·
Excited to share that I’ve been promoted to Full Prof 😊! Honored to be the first woman @LSEHealthPolicy to reach this milestone—and hopeful for many more to follow soon... Thanks to my family + friends, mentors & the colleagues who have supported me along the way.
English
9
2
58
2K
Arianna Gentilini me-retweet
Kristina Jenei
Kristina Jenei@kjmeetswrld·
✨Chuffed to have won the best presentation at @UUUIPS Winter Meeting. Was a great time hearing about different projects at all different cross-sections and meet the policy faculty. @LSEHealthPolicy
Kristina Jenei tweet media
English
2
3
11
517
Arianna Gentilini
Arianna Gentilini@agentilini_·
6/ 📌 While NICE considers many patient-relevant issues, there's room for improvement to ensure all concerns are considered. Increasing diversity of viewpoints and clarifying the management of conflicts of interest can further strengthen the process.
English
1
0
1
71
Arianna Gentilini
Arianna Gentilini@agentilini_·
1/ 📢 New paper out today in the Eur J Health Econ with Alina Rana! We reviewed patient submissions to 15 NICE Highly Specialised Technology appraisals to see how patient voices are considered in decision-making. Full article below 👇🏼 link.springer.com/article/10.100…
English
1
3
9
946
Arianna Gentilini me-retweet
Dario Trapani
Dario Trapani@darioT_·
In this latest work, @KanavosPG et al from @LSEHealthPolicy provide a validation exercise on the use of @myESMO #MCBS as a tool to aid in decision-making for #cancer drugs. #HTA A next step toward #value -based healthcare, more to come on this! ✔️ @VriesElisabeth
Kristina Jenei@kjmeetswrld

thelancet.com/journals/lanon… Great study by @KanavosPG @aris_angelis and Erica Visintin on the use of @myESMO in #HTA recommendations. cc: @LSEHealthPolicy

English
1
2
6
804
Arianna Gentilini me-retweet
LSE Health Policy
LSE Health Policy@LSEHealthPolicy·
🚨New Research by @IvaParvanova01 & @agentilini_ on the EU's 24 COI regulation in JCA. 🌟 📊 Key findings: ✔️Progress in transparency for EU-wide HTAs. ✔️Concerns on expert diversity & COI enforcement. ✔️Recs for stronger accountability. 🔗Read now👇bmjopen.bmj.com/content/14/11/…
LSE Health Policy tweet media
English
0
2
5
352
Arianna Gentilini me-retweet
Iva Parvanova
Iva Parvanova@IvaParvanova01·
🚨@agentilini_ and I analyze the new COI regulation for EU HTA (#JCA) @BMJ_Open, key points: ✍️No guidance for disclosing the size of financial interests ⚖️No COI mitigation for experts from conflicted orgs or conflicted experts (esp for rare diseases) 👉tinyurl.com/j5y6zkau
English
1
3
7
453
Arianna Gentilini me-retweet
Investigate Europe
Investigate Europe@investigate_eu·
UK patient organisations took €20m from drug companies in 2022, followed by groups in Belgium, France, Italy and Germany. In a first Europe-wide study, our investigation reveals 11,000+ payments made by pharma industry to advocacy groups and charities: investigate-europe.eu/posts/deadly-p…
English
0
7
5
2.1K

Jelajahi

@mylene_lagarde @LSEHealthPolicy @DSE_Unibo @UUUIPS @ImperialBiz @consiliumsci @IvaParvanova01 @KanavosPG